GARFIELD ALASTAIR (Chief Scientific Officer) exercised options at RHYTHM PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/2/2026ACC: 0001104659-26-080397
Officer· Chief Scientific Officer
Since Feb 2026
-2.15K
Net shares
Net seller
$237.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
4.45K acquired · 6.59K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.45K
Price / share
—
Trade value
—
% of position
57.3%
7/1/2026
7.76K→12.21K
Common Stock
Direct
Shares
−2.15K
Price / share
$110.41
Trade value
$237.38K
% of position
17.6%
7/1/2026
12.21K→10.06K
Total
Net shares
+2.29K
Net value
-$237.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +4.45K | — | — | 57.3% | 7.76K | 12.21K |
| Common Stock Direct | 7/1/2026 | F · Tax Withholding | −2.15K | $110.41 | $237.38K | 17.6% | 12.21K | 10.06K |
| Total | +2.29K | -$237.38K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
4.45K shares
Shares
−4.45K
Strike price
Held after
8.89K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4.45K shares | 7/1/2026 | M · Option Exercise | −4.45K | — | 8.89K |